| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102666538-B |
| titleOfInvention |
Pyrrolopyridinylpyri-idin-idin 2-ylamine derivatives |
| abstract |
The Pyrrolopyridinylpyri-idin-idin 2-ylamine derivatives of formula (I) is the inhibitor of cell proliferation/cell vitality, can be used for treating tumour, wherein Rn 1 -Rn 6 and Rn 1 there is the implication shown in claim 1. |
| priorityDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |